Table 3.
Total sample | Propensity matched sample | |||
---|---|---|---|---|
HR (95% CI) | p-Value | HR (95% CI) | p-Value | |
All-cause mortality | ||||
Univariate model | 1.64 (1.39–1.93) | < 0.001 | 1.43 (1.13–1.80) | 0.002 |
Multivariate model 1 | 1.40 (1.19–1.66) | < 0.001 | 1.37 (1.09–1.73) | 0.006 |
Multivariate model 2 | 1.43 (1.21–1.69) | < 0.001 | 1.40 (1.11–1.76) | 0.004 |
Multivariate model 3 | 1.49 (1.26–1.76) | < 0.001 | 1.40 (1.12–1.77) | 0.004 |
Multivariate model 4 | 1.45 (1.22–1.70) | < 0.001 | 1.41 (1.12–1.78) | 0.004 |
End-stage renal disease | ||||
Univariate model | 1.01 (0.81–1.25) | 0.97 | 1.10 (0.82–1.48) | 0.52 |
Multivariate Model 1: Adjusted for age, gender, ethnicity
Multivariate Model 2: Adjusted for all covariates of model 1 plus smoking, alcohol, hypertension, diabetes mellitus
Multivariate Model 3: Adjusted for all covariates of model 2 plus ischaemic heart disease, myocardial infarction, congestive cardiac failure, cerebro vascular accident, peripheral vascular disease
Multivariate Model 4: Adjusted for all covariates of model 3 plus estimated glomerular filtration rate (CKD-EPI)
HR-Hazard ratio, CI-Confidence interval. Statistically significant p-values are displayed in bold (i.e. p < 0.05)